Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Bridion |
| Active Ingredient: | Sugammadex 100mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Merck Sharp & Dohme (New Zealand) Limited |
| Manufacturers: | NV Organon, Oss, Netherlands Patheon Manufacturing Services LLC, North Carolina, United States of America |
| Product: | RINVOQ |
| Active Ingredient: | Upadacitinib hemihydrate 15.4mg equivalent to upadacitinib 15mg |
| Dosage Form: | Modified release tablet |
| New Zealand Sponsor: | AbbVie Limited |
| Manufacturer: | AbbVie Ireland NL B.V., Sligo, Ireland |
Dated this 29th day of July 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).